Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.2M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
21.9M
-
Shares change
-
-3.38M
-
Total reported value, excl. options
-
$90.6M
-
Value change
-
-$15.6M
-
Put/Call ratio
-
1.17
-
Number of buys
-
30
-
Number of sells
-
-59
-
Price
-
$4.13
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q2 2021
109 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q2 2021.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.9M shares
of 55.2M outstanding shares and own 39.75% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (6.39M shares), ARMISTICE CAPITAL, LLC (3.72M shares), VANGUARD GROUP INC (2.17M shares), CITADEL ADVISORS LLC (1.61M shares), BlackRock Inc. (943K shares), JPMORGAN CHASE & CO (920K shares), Erste Asset Management GmbH (743K shares), FEDERATED HERMES, INC. (678K shares), ACADIAN ASSET MANAGEMENT LLC (667K shares), and MILLENNIUM MANAGEMENT LLC (518K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.